STAT+: Talawar bets bispecific approach can shake up eczema market

Moderna still bullish on mRNA, Ipsen's acquisition of Kartos, and more biotech news from The Readout
Related Markets
All MarketsMarket data may be delayed. Not financial advice.
💡 AI analysis provides alternative perspectives on current events